A Phase III, Randomized, Double-Blind, Active-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Tegoprazan for the Prevention of Peptic Ulcer in Patients on Continuous Long-Term Treatment with Nonsteroidal Anti-Inflammatory Drugs

Sang Gyun Kim, Tae-Oh Kim, Sung Woo Jung, Byung-Hoon Min, Jung-Hwan Oh, Hyun-Soo Kim, Gil Ho Lee, Ji Hyun Song, In Kyung Sung, Young Sin Cho, Suck Chei Choi, Yun Jeong Lim, Byung-Wook Kim, Cheol Min Shin, Cheal Wung Huh, Ji Won Kim, Kyung-Oh Kim, Yu Kyung Cho, Oh Young Lee, Jeong Seop Moon, Hyun Woo Lee, Hwoon-Yong Jung, Woon Geon Shin, Jae-Gyu Kim, Ju Yup Lee, Su Jung Han, Sang-Wook Kim, Joon Hyun Cho, Hyun Lim, Tae Ho Kim, Moo In Park, Gwang Ho Baik, Ra Ri Cha, Sang Kil Lee, Jae J Kim · 2026

Read A Phase III, Randomized, Double-Blind, Active-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Tegoprazan for the Prevention of Peptic Ulcer in Patients on Continuous Long-Term Treatment with Nonsteroidal Anti-Inflammatory Drugs by Sang Gyun Kim, Tae-Oh Kim, Sung Woo Jung, Byung-Hoon Min, Jung-Hwan Oh, Hyun-Soo Kim, Gil Ho Lee, Ji Hyun Song, In Kyung Sung, Young Sin Cho, Suck Chei Choi, Yun Jeong Lim, Byung-Wook Kim, Cheol Min Shin, Cheal Wung Huh, Ji Won Kim, Kyung-Oh Kim, Yu Kyung Cho, Oh Young Lee, Jeong Seop Moon, Hyun Woo Lee, Hwoon-Yong Jung, Woon Geon Shin, Jae-Gyu Kim, Ju Yup Lee, Su Jung Han, Sang-Wook Kim, Joon Hyun Cho, Hyun Lim, Tae Ho Kim, Moo In Park, Gwang Ho Baik, Ra Ri Cha, Sang Kil Lee, Jae J Kim (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13364759.txt.

Description

Sang Kim leads a wide team in a 2026 phase three trial of tegoprazan, a new fast acid block drug, to guard the gut of folks on long pain drug care. Pain drugs raise ulcer risk. Near four hundred patients took one of two guard drugs for up to 24 weeks.

The new drug matched the old guard drug on ulcer block, the main test. Heartburn free rates at week 12 ran higher on the new drug. Harm rates were low and near the same in both arms. The trial backs the new drug as a sound guard choice.

Catalog record

CREATORSang Gyun Kim, Tae-Oh Kim, Sung Woo Jung, Byung-Hoon Min, Jung-Hwan Oh, Hyun-Soo Kim, Gil Ho Lee, Ji Hyun Song, In Kyung Sung, Young Sin Cho, Suck Chei Choi, Yun Jeong Lim, Byung-Wook Kim, Cheol Min Shin, Cheal Wung Huh, Ji Won Kim, Kyung-Oh Kim, Yu Kyung Cho, Oh Young Lee, Jeong Seop Moon, Hyun Woo Lee, Hwoon-Yong Jung, Woon Geon Shin, Jae-Gyu Kim, Ju Yup Lee, Su Jung Han, Sang-Wook Kim, Joon Hyun Cho, Hyun Lim, Tae Ho Kim, Moo In Park, Gwang Ho Baik, Ra Ri Cha, Sang Kil Lee, Jae J Kim
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26984
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13364759

Browse the full library · About the Tower of Babel